Neutrophil activation in thermal injury as assessed by increased expression of complement receptors
- PMID: 2938005
- DOI: 10.1056/NEJM198604103141503
Neutrophil activation in thermal injury as assessed by increased expression of complement receptors
Abstract
We studied neutrophil activation in patients with burns by serial immunofluorescent measurement of neutrophil expression of the complement opsonin receptors CR1 and CR3. CR1-dependent fluorescence was initially (days 0 through 5 after the burn) elevated (mean +/- SEM, 294 +/- 42 vs. 63 +/- 6 in the controls; P less than 0.001) and gradually returned to normal (days 6 through 8, 270 +/- 62, P less than 0.001; days 9 through 13, 185 +/- 38, P less than 0.001; days 14 through 19, 143 +/- 27, P less than 0.001; and days 20 through 50, 93 +/- 5, P less than 0.04). CR3-dependent fluorescence paralleled that of CR1. Neutrophil chemotaxis in response to zymosan-activated serum, a source of C5a, was depressed (days 0 through 5, 77 +/- 4 percent of control, P less than 0.001; days 6 through 8, 70 +/- 4 percent, P less than 0.001; days 9 through 13, 74 +/- 3 percent, P less than 0.001; days 14 through 19, 90 +/- 4 percent, P less than 0.01; and days 20 through 50, 97 +/- 3 percent, P not significant) and inversely correlated with CR1- and CR3-dependent fluorescence (r = -0.559, P less than 0.001; and r = -0.709, P less than 0.001, respectively). Plasma C3a desArg levels were above normal (100 +/- 5 ng per milliliter) throughout (days 0 through 5, 305 +/- 42; days 6 through 8, 546 +/- 69; days 9 through 13, 490 +/- 72; days 14 through 19, 409 +/- 54; and days 20 through 50, 260 +/- 36; all P less than 0.005). Thus, neutrophils in burned patients were activated as indicated by increased expression of complement receptors. The correlation between this increase and the depression of chemotaxis in response to zymosan-activated serum suggests that C5a is responsible for systemic neutrophil activation, which may contribute to the increased susceptibility to infection of patients with burns.
Similar articles
-
Neutrophil activation after burn injury: contributions of the classic complement pathway and of endotoxin.Surgery. 1987 Sep;102(3):477-84. Surgery. 1987. PMID: 3307005
-
Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation.Surgery. 1981 Aug;90(2):319-27. Surgery. 1981. PMID: 7256544
-
Complement-induced expression of cryptic receptors on the neutrophil surface: a mechanism for regulation of acute inflammation in trauma.Surgery. 1984 Aug;96(2):336-44. Surgery. 1984. PMID: 6087484
-
Neutrophil disorders in burn injury: complement, cytokines, and organ injury.J Trauma. 1990 Dec;30(12 Suppl):S80-5. doi: 10.1097/00005373-199012001-00019. J Trauma. 1990. PMID: 2254997 Review.
-
Infections in burn patients: a paradigm for cutaneous infection in the patient at risk.Am J Med. 1984 May 15;76(5A):158-65. doi: 10.1016/0002-9343(84)90259-6. Am J Med. 1984. PMID: 6372465 Review.
Cited by
-
Complement receptor expression on neutrophils at an inflammatory site, the Pseudomonas-infected lung in cystic fibrosis.J Clin Invest. 1989 Oct;84(4):1302-13. doi: 10.1172/JCI114298. J Clin Invest. 1989. PMID: 2507578 Free PMC article.
-
Insights into the Role of Chemokines, Damage-Associated Molecular Patterns, and Lymphocyte-Derived Mediators from Computational Models of Trauma-Induced Inflammation.Antioxid Redox Signal. 2015 Dec 10;23(17):1370-87. doi: 10.1089/ars.2015.6398. Antioxid Redox Signal. 2015. PMID: 26560096 Free PMC article. Review.
-
Neutrophil elastase cleaves C3bi on opsonized pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch.J Clin Invest. 1990 Jul;86(1):300-8. doi: 10.1172/JCI114699. J Clin Invest. 1990. PMID: 2164045 Free PMC article.
-
Inhibition of the alternative C3 convertase and classical C5 convertase of complement by group A streptococcal M protein.Infect Immun. 1990 Aug;58(8):2535-41. doi: 10.1128/iai.58.8.2535-2541.1990. Infect Immun. 1990. PMID: 2142480 Free PMC article.
-
Novel pharmacotherapy for burn wounds: what are the advancements.Expert Opin Pharmacother. 2019 Feb;20(3):305-321. doi: 10.1080/14656566.2018.1551880. Epub 2018 Dec 5. Expert Opin Pharmacother. 2019. PMID: 30517046 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical